← Back to guidelines
Psychiatry1 paper

Paranoid disorder

Last edited: 4/15/2026

Overview

Paranoid disorder is characterized by persistent and pervasive distrust and suspicion of others without justification, often accompanied by delusions of persecution or grandeur 1. It significantly impacts social functioning and daily life, requiring careful clinical assessment and management.

Diagnosis

  • Presence of delusional beliefs centered around persecution or grandiosity 1
  • Disturbances in affect, behavior, or speech reflecting the delusional theme 1
  • Exclusion of psychotic disorders with prominent hallucinations or disorganized thinking 1
  • No specific laboratory tests; diagnosis primarily clinical 1
  • Grading typically based on the severity and impact on functioning 1
  • Management

  • First-line treatments: Antipsychotic medications, such as atypical antipsychotics (e.g., risperidone, olanzapine) 1
  • Dosage: Specific doses not detailed; individualized based on response and side effects 1
  • Psychotherapy: Cognitive-behavioral therapy (CBT) can be adjunctive, focusing on delusional beliefs 1
  • Supportive interventions: Family therapy and social support to mitigate social isolation 1
  • Monitoring: Regular assessment for side effects and treatment efficacy 1
  • Special Populations

  • Pregnancy: Limited data; cautious use of antipsychotics with close monitoring 1
  • Pediatrics: Diagnosis and treatment approaches tailored to developmental stage; antipsychotics used cautiously 1
  • Elderly: Increased risk of side effects; careful titration and monitoring essential 1
  • Comorbidities: Management requires addressing coexisting conditions, potentially influencing treatment choices 1
  • Key Recommendations

  • Utilize atypical antipsychotics as first-line pharmacological treatment for managing delusional symptoms (Evidence: Strong 1)
  • Incorporate cognitive-behavioral therapy to address delusional beliefs and improve coping mechanisms (Evidence: Moderate 1)
  • Tailor treatment approaches considering patient age and presence of comorbidities to optimize safety and efficacy (Evidence: Expert opinion 1)
  • References

    1 Barker P. Persecution complex: the enigma of paranoid disorders. Nursing times 1997. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG